Continuous Glucose Monitoring clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
This randomized controlled trial will investigate whether use of continuous glucose monitoring (CGM) vs. usual care with self-monitored blood glucose 1) enhances glycemic control, 2) reduces hypoglycemia risk, and 3) improves quality of life, diabetes distress, and fear of hypoglycemia in hemodialysis patients with diabetes mellitus.
Our lead scientists for Continuous Glucose Monitoring research studies include Connie Rhee.